GE Healthcare Announces Collaboration to Advance Digital Transformation of Pathology

A partnership to foster Enterprise imaging and pathology for oncology The collaboration intends to bring a data management solution by interfacing Tribun’s Health Suite data into GE Healthcare’s products Buc, France – October 18, 2022 – GE Healthcare and Tribun Health have entered a collaboration with the intent to provide digital pathology departmental solutions that... Read more

Telix Partnership Expands GE Healthcare Immuno-Diagnostics Offering to the Global Clinical Research Market

New agreement adds two Telix investigational PET imaging radiotracers to GE Healthcare’s immuno-diagnostic portfolio, to enable patient selection and monitoring in immunotherapy trials Telix tracers evaluate levels of carbonic anhydrase IX and lactate in tumours to inform and improve therapy selection GE Healthcare’s Pharmaceutical Diagnostics business is an established global supplier of PET imaging tracers... Read more

GE Healthcare Introduces Omni Legend: A First-of-its-Kind All-Digital PET/CT System to Drive Efficiency, Enhance Diagnostics, and Deliver on Precision Medicine

Chicago, U.S. and Barcelona, Spain – October 16, 2022 – At the European Association of Nuclear Medicine (EANM) Annual Meeting, GE Healthcare proudly introduces Omni Legend[i], the first system on its all-new, all-digital PET/CT platform. This cutting-edge system features a brand-new category of digital BGO (dBGO) detector material with a small crystal size that delivers... Read more

Thermo Fisher Scientific Prices Offering of Yen-Denominated Senior Notes

WALTHAM, Mass.–(BUSINESS WIRE)– Thermo Fisher Scientific Inc. (NYSE: TMO) (“Thermo Fisher”) the world leader in serving science, announced today that it has priced an offering of ¥109.5 billion aggregate principal amount (the “Offering”) of the following yen-denominated notes, each issued at par: ¥22,300,000,000 aggregate principal amount of its 0.853% Senior Notes due 2025 (the “2025... Read more

Cytel to acquire SDS Life Science and SDS MedteQ to enhance and expand thought-leadership in strategic therapeutic development 

Waltham, MA, October 13, 2022 – Cytel Inc., provider of quantitative insights and health data analytics to leaders in life sciences, has entered into an agreement to acquire SDS Life Science AB and SDS MedteQ AB. The move will add new global talent to Cytel’s Strategic Consulting group and bring additional expertise and capabilities for the... Read more

GE Healthcare Announces Multi-Year Agreement with SQM to Secure Iodine Supply for Contrast Media

Enables GE Healthcare to secure increasing supply of iodine, a key ingredient for contrast media products used in X-Ray and Computed Tomography (CT) imaging procedures Supports GE Healthcare’s broader commitment to address future demand for iodinated contrast media and deliver 30 million more patient doses annually by 2025 Investment plan also includes opening this week... Read more

Agilent Opens Center of Excellence for Dissolution Products

SANTA CLARA, Calif., October 12, 2022  Agilent Technologies Inc. (NYSE: A) today announced the opening of the Dissolution Center of Excellence (CoE) facility in Craven Arms, United Kingdom. The newly modernized premises will house the core of Agilent’s dissolution business, including research and development, quality, support, applications, marketing, and more. This investment allows all Agilent dissolution... Read more